Vilanterol Triphenylacetate API

Name	Vilanterol triphenylacetate
Chinese name	三苯乙酸维兰特罗
Cas Number	503070-58-4
Source	India
Qualifications	-/-/-/-/-

Veranterol is an inhaled ultra-long-acting β2 adrenergic receptor agonist. In 2018, GlaxoSmithKline (GSK)'s Umebride/Villanterol inhalation powder (Olexin) was approved for marketing in China. The inhalant contains two bronchodilator components: one is a long-acting anti The cholinergic drug umelonium bromide, the second is the long-acting β2 receptor agonist vilanterol. As the first dual bronchodilator to be marketed in China, umelonium bromide/vilanterol inhalation powder aerosol (Olexin) is the first and only one that has been confirmed by head-to-head studies to have stronger lungs than existing bronchodilator Double bronchodilator with improved function and greater quality of life. The product has been widely recognized internationally, has been approved for marketing in 98 countries and regions, and has been included in the medical insurance catalogs of 47 countries and regions. The results of a clinical study by GlaxoSmithKline (GSK) confirmed that its chronic obstructive pulmonary maintenance treatment drug Umebromium Bromide/Vilanterol can effectively improve lung function (FeV1 trough).

Hot Tags: vilanterol triphenylacetate api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Paliperidone API, Linagliptin API, Active Pharmaceutical Ingredient, Canagliflozin API, Perindopril Tert butylamine Salt API, Tetrabenazine API

• Previous: Efluconazole API
• Next: Sofosbuvir/Sofosbuvir API